|Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts|
SR Radfar, RA Rawson
Addiction & health 6 (3-4), 146, 2014
|Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran|
S Zamani, R Radfar, P Nematollahi, R Fadaie, M Meshkati, S Mortazavi, ...
International Journal of Drug Policy 21 (6), 493-500, 2010
|Predictors of continued use of extended-released naltrexone (XR-NTX) for opioid-dependence: an analysis of heroin and non-heroin opioid users in Los Angeles County|
SJ Cousins, SR Radfar, D Crèvecoeur-MacPhail, A Ang, K Darfler, ...
Journal of substance abuse treatment 63, 66-71, 2016
|Methamphetamine use among patients undergoing methadone maintenance treatment in Iran; a threat for harm reduction and treatment strategies: A qualitative study|
SR Radfar, SJ Cousins, S Shariatirad, A Noroozi, RA Rawson
Int J High Risk Behav Addict 5 (4), e30327, 2016
|Behaviors influencing human immunodeficiency virus transmission in the context of positive prevention among people living with HIV/acquired immunodeficiency syndrome in Iran: a …|
SR Radfar, A Sedaghat, AT Banihashemi, M Gouya, RA Rawson
International journal of preventive medicine 5 (8), 976, 2014
|Practical guidelines on how to provide consulting services in behavioral disorders centers|
S Radfar, K Taheri, H Namdari Tabar
Tehran: Ministry of Health and Medical Education, 2009
|COVID-19 and substance use disorders: recommendations to a comprehensive healthcare response. An international society of addiction medicine (ISAM) practice and policy interest …|
A Farhoudian, A Baldacchino, N Clark, G Gerra, H Ekhtiari, G Dom, ...
Autonomic Neuroscience: Basic & Clinical 11 (2), 129-146, 2020
|Lead poisoning among opium users in Iran, a possible new emerging epidemic in the region|
SR Radfar, P Nematollahi, A Farhoudian, A Noroozi
Iranian Journal of Public Health 46 (8), 1152-1153, 2017
|Factors Influencing Access and Use of Care and Treatment SerČvices among Iranian People Living with HIV and AIDS: A QualiČtative Study|
SR Radfar, P Nematollahi, M Arasteh
Iranian journal of public health 45 (1), 109-111, 2016
|The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?|
H Ekhtiari, A Noroozi, A Farhoudian, SR Radfar, A Hajebi, S Sefatian, ...
|Study on Prevalence of Alcohol Abuse among Injecting Drug Users in Tehran and 5 Major Cities of Iran|
SR Radfar, A Noroozi, K Tayeri, A Motavalian, P Nematollahi, ...
Asia Pacific Journal of Medical Toxicology 3 (Supplement 1), 20-20, 2014
|Integration of Methamphetamine Harm Reduction into Opioid Harm Reduction Services in Iran: Preliminary Results of a Pilot Study|
SR Radfar, S Mohsenifar, A Noroozi
Iranian Journal of Psychiatry and Behavioral Sciences, 2017
|Integration of outpatient alcohol treatment services in substance abuse treatment centers: An introduction to the first national program in Iran.|
S Shariatirad, O Massah, A Farhoudian, SR Radfar, N Molavi, ...
The International journal on drug policy 29, 100, 2016
|Possible Overlap of Laboratory Findings Between Patients with COVID-19 and Drug Users|
A Farhoudian, P Nematollahi, M Sadeghi, SR Radfar
Archives of Clinical Infectious Diseases, 2020
|Integration of outpatient alcohol treatment in drug use disorder treatment centers in Iran: Study protocol|
SS Hashemian, A Noroozi, O Massah, SR Radfar, R Daneshmand, ...
Iranian Journal of Psychiatry and Behavioral Sciences 11 (2), 2017
|Ways to increase coverage of harm reduction programs in women-friendly facilities in Iran: a qualitative study|
CPDD 75th annual meeting, 2013, California: USA, 2013
|Isolation of hepatitis C virus in norjizac vials|
K Tayeri, SR Radfar, M Yaran, N Kassaian, Z Nokhodian, B Ataei, ...
Hepatitis Monthly 10 (1), 65, 2010
|An Epidemiological Study of Psychiatric Disorders in Lorestan Province (Year 2001)|
MR MOHAMMADI, AH MALEK, AA NOURBALA, YSA BAGHERI, ...
YAFTEH 5 (19), 3-14, 2004
|COVID-19 and Substance Use Disorder: Study Protocol for the International Society of Addiction Medicine Practice and Policy Interest Group Global Survey|
A Baldacchino, SR Radfar, C De Jong, P Rafei, M Yunesian, G Gerra, ...
Basic and Clinical Neuroscience 11 (2), 155-162, 2020
|Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran|
G Moradi, B Hajarizadeh, K Rahmani, A Mohamadi-Bolbanabad, ...
International Journal of Drug Policy 73, 129-134, 2019